Blueprint for a stronger Food and Drug Administration

N Engl J Med. 2006 Oct 26;355(17):1821. doi: 10.1056/NEJMe068237. Epub 2006 Oct 9.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adverse Drug Reaction Reporting Systems / organization & administration*
  • Advisory Committees
  • Drug Approval*
  • Drug Labeling
  • Humans
  • National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division
  • United States
  • United States Food and Drug Administration / organization & administration*